Related Experiment Video
Updated: Jun 16, 2026
11:17
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Minority participation in randomized controlled trials for obsessive-compulsive disorder
Monnica Williams1, Mark Powers, Yeo-Gin Yun
1Center for the Treatment and Study of Anxiety, University of Pennsylvania, School of Medicine, Department of Psychiatry, Philadelphia, PA 19104, United States. monnica@mail.med.upenn.edu
Journal of Anxiety Disorders
|February 10, 2010
Summary
Minority groups are underrepresented in North American clinical trials for obsessive-compulsive disorder (OCD). This lack of diversity means current OCD treatments may not be effective for all populations.
Area of Science:
- Psychiatry
- Clinical Research
- Health Disparities
Background:
- Clinical trials are essential for developing effective treatments for obsessive-compulsive disorder (OCD).
- Ensuring diverse representation in these trials is crucial for treatment generalizability.
Purpose of the Study:
- To determine if minority groups are underrepresented in published randomized clinical trials for OCD in North America.
- To assess the ethnic and racial demographics of participants in OCD trials.
Main Methods:
- A systematic review of randomized controlled trials (RCTs) for OCD in adults and children conducted in North America from 1989 to 2009.
- Analysis of 40 trials (N=3777), focusing on 21 trials (N=2221) that reported ethnic/racial data.
Main Results:
- Only 22 of 40 trials reported ethnic/racial information.
- In the analyzed trials, 91.5% of participants were Caucasian, with minorities (African-American, Hispanic, Asian, Other) comprising only 5.4% of the total.
- 3.1% of participants had unknown ethnicity/race.
Conclusions:
- Minority groups are significantly underrepresented in North American OCD clinical trials.
- The efficacy of empirically validated OCD treatments for minority populations remains largely unknown.
- Recommendations are needed to improve minority recruitment in future OCD research.
Related Concept Videos
01:28Obsessive-Compulsive Disorder
Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
01:13Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:24Operant Conditioning Intervention
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
In operant conditioning, behaviors that are...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...